Human Leukocyte Antigen-DR Deficiency and Immunosuppression-Related End-Organ Failure in SARS-CoV2 Infection
- PMID: 32925313
- PMCID: PMC7386673
- DOI: 10.1213/ANE.0000000000005140
Human Leukocyte Antigen-DR Deficiency and Immunosuppression-Related End-Organ Failure in SARS-CoV2 Infection
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
Comment on
-
Reduced Monocytic Human Leukocyte Antigen-DR Expression Indicates Immunosuppression in Critically Ill COVID-19 Patients.Anesth Analg. 2020 Oct;131(4):993-999. doi: 10.1213/ANE.0000000000005044. Anesth Analg. 2020. PMID: 32925314 Free PMC article.
References
-
- Venet F, Tissot S, Debard AL, et al. Decreased monocyte human leukocyte antigen-DR expression after severe burn injury: correlation with severity and secondary septic shock. Crit Care Med. 2007;35:1910–1917. - PubMed
-
- Venet F, Rimmelé T, Monneret G. Management of sepsis-induced immunosuppression. Crit Care Clin. 2018;34:97–106. - PubMed
-
- Volk HD, Thieme M, Heym S, et al. Alterations in function and phenotype of monocytes from patients with septic disease—predictive value and new therapeutic strategies. Behring Inst Mitt. 1991:208–215. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous
